Wilson’s disease is a genetic disorder caused by the loss of function of the ATP7B copper-binding protein that leads to impaired copper transport and excretion, which results in accumulation of free copper in the bloodstream that results in damage of liver, brain, and other organs. As Wilson’s disease is hard to differentiate from other serious hepatic or neurologic condition that result in less number of patient to be diagnosed than the actual prevalence of Wilson’s disease. Wilson’s disease is characterized by the degree of accumulation of free copper in liver and the brain. Whereas, the patients that suffer from Wilson’s disease can either be asymptomatic or can have one or more clinical symptoms which can vary in type and its severity that include liver disease, neurologic manifestations and psychiatric disturbances. The symptoms for Wilson’s disease may include abdominal pain, lack of appetite, fatigue, jaundice, problems with speech, swallowing or physical coordination and uncontrolled movements or muscle stiffness.
Increasing awareness regarding Wilson’s disease and its symptoms is expected to fuel the market of Wilson’s disease treatment market in the near future. Moreover, growing population all over the world is expected to boost the growth of Wilson’s disease market.
In 2018, the global Wilson`s Disease Treatment market size was 420 million US$ and it is expected to reach 660 million US$ by the end of 2025, with a CAGR of 6.0% during 2019-2025.
This report focuses on the global Wilson`s Disease Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Wilson`s Disease Treatment development in United States, Europe and China.
The key players covered in this study
Valeant Pharmaceuticals International
Tsumura & Co
Merck & Co
VHB Life Science Inc.
Teva Pharmaceuticals USA, Inc
Wilson’s Therapeutics AB
Noble Pharma Co., Ltd
Kadmon Holding, Inc
Market segment by Type, the product can be split into
Medications
Others
Market segment by Application, split into
Government
Hospitals
Medical Practitioners
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Wilson`s Disease Treatment status, future forecast, growth opportunity, key market and key players.
To present the Wilson`s Disease Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Wilson`s Disease Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Summary:
Get latest Market Research Reports on Wilson`s Disease Treatment . Industry analysis & Market Report on Wilson`s Disease Treatment is a syndicated market report, published as Global Wilson`s Disease Treatment Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Wilson`s Disease Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.